Paul R.  Kirchgraber net worth and biography

Paul Kirchgraber Biography and Net Worth

CEO of Labcorp
Dr. Paul R. Kirchgraber serves as Executive Vice President and Chief Executive Officer - Covance Drug Development of the Company. From July 2018 until then, Dr. Kirchgraber served as Senior Vice President and head of Covance’s clinical trial testing solutions, and he served as Senior Vice President of Central Laboratories from April 2015 until July 2018. He served as Vice President and General Manager of Americas with Covance Central Laboratories from 2012 until 2015. Prior to that Dr. Kirchgraber served as Vice President Global Laboratory Operations and Medical Affairs with Covance Central Laboratory from 2009 – 2015. Prior to joining the Company, Dr. Kirchgraber also served at Quintiles Laboratories Ltd as Vice President and Global Medical Director where he was responsible for oversight of wholly owned laboratories in the U.S., Singapore, South Africa, India, and China and as Senior Director of Laboratory Services/ North American Medical Director where he had operational responsibility for laboratory and specimen management departments and was the medical director of the U.S. laboratory. Dr. Kirchgraber received his medical degree from Cornell University and his Master’s degree in Business Administration from Binghamton University, and he holds three board certifications from the American Board of Pathology.

What is Paul R. Kirchgraber's net worth?

The estimated net worth of Paul R. Kirchgraber is at least $3.38 million as of May 19th, 2023. Dr. Kirchgraber owns 12,946 shares of Labcorp stock worth more than $3,384,343 as of December 5th. This net worth evaluation does not reflect any other assets that Dr. Kirchgraber may own. Learn More about Paul R. Kirchgraber's net worth.

How do I contact Paul R. Kirchgraber?

The corporate mailing address for Dr. Kirchgraber and other Labcorp executives is 358 South Main Street, BURLINGTON NC, 27215. Labcorp can also be reached via phone at (336) 229-1127 and via email at [email protected]. Learn More on Paul R. Kirchgraber's contact information.

Has Paul R. Kirchgraber been buying or selling shares of Labcorp?

Paul R. Kirchgraber has not been actively trading shares of Labcorp during the past quarter. Most recently, Paul R. Kirchgraber sold 4,300 shares of the business's stock in a transaction on Friday, May 19th. The shares were sold at an average price of $216.91, for a transaction totalling $932,713.00. Following the completion of the sale, the chief executive officer now directly owns 12,946 shares of the company's stock, valued at $2,808,116.86. Learn More on Paul R. Kirchgraber's trading history.

Who are Labcorp's active insiders?

Labcorp's insider roster includes Kerrii Anderson (Director), Jean-Luc Belingard (Director), Lance Berberian (EVP), Brian Caveney (EVP), Jonathan DiVincenzo (EVP and President, Central Laboratories and International), Glenn Eisenberg (CFO), Dwight Gilliland (Director), Paul Kirchgraber (CEO), Peter Neupert (Director), Richelle Parham (Director), Adam Schechter (Chairman, President, and CEO), Mark Schroeder (EVP), Amy Summy (CMO), Sandra van der Vaart (EVP), Peter Wilkinson (CAO), and R. Williams (Director). Learn More on Labcorp's active insiders.

Are insiders buying or selling shares of Labcorp?

During the last year, insiders at the medical research company sold shares 19 times. They sold a total of 54,892 shares worth more than $14,048,330.71. The most recent insider tranaction occured on November, 11th when CEO Adam H Schechter sold 5,745 shares worth more than $1,509,498.75. Insiders at Labcorp own 0.8% of the company. Learn More about insider trades at Labcorp.

Information on this page was last updated on 11/11/2025.

Paul R. Kirchgraber Insider Trading History at Labcorp

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/19/2023Sell4,300$216.91$932,713.0012,946View SEC Filing Icon  
2/21/2023Sell8,000$250.58$2,004,640.009,069View SEC Filing Icon  
5/6/2021Sell2,500$276.55$691,375.007,844View SEC Filing Icon  
11/4/2020Sell1,500$214.14$321,210.007,698View SEC Filing Icon  
See Full Table

Paul R. Kirchgraber Buying and Selling Activity at Labcorp

This chart shows Paul R Kirchgraber's buying and selling at Labcorp by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Labcorp Company Overview

Labcorp logo
Labcorp Holdings, Inc. engages in providing medical testing services. The company was founded on April 16, 2024 and is headquartered in Burlington, NC.
Read More

Today's Range

Now: $261.42
Low: $259.42
High: $265.56

50 Day Range

MA: $269.95
Low: $245.96
High: $291.34

2 Week Range

Now: $261.42
Low: $209.38
High: $293.72

Volume

861,158 shs

Average Volume

928,922 shs

Market Capitalization

$21.67 billion

P/E Ratio

25.68

Dividend Yield

1.08%

Beta

0.99